ARTICLE | Clinical News
SmithKline regulatory update
April 15, 2013 7:00 AM UTC
The FDA granted marketing approval for Requip ropinirole to treat the signs and symptoms of Parkinson's disease. The product can be used as an initial therapy and as adjunctive treatment with levodo...